<DOC>
	<DOCNO>NCT00800176</DOCNO>
	<brief_summary>This 6 arm study evaluate efficacy , safety pharmacokinetics 5 dos RO4998452 compare placebo patient type 2 diabetes mellitus . Patients randomize one 6 group receive RO4998452 dose 2.5mg , 5mg , 10mg , 20mg 40mg po daily , placebo daily . Patients pre-treated stable metformin continue take usual dose metformin throughout study.The anticipated time study treatment &lt; =3 month</brief_summary>
	<brief_title>A Dose-Finding Study RO4998452 Patients With Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>adult patient , 1875 year age ; type 2 diabetes , diagnose &gt; =3 month ; either treat diet , exercise stable metformin , diet exercise alone . type 1 diabetes mellitus ; currently within 2 month prior screen treat oral injectable antidiabetic agent except stable dos metformin ; currently within 6 month prior screen treat PPARgamma agonist ; uncontrolled hypertension ; significant prediagnosed diabetic complication require treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>